Initial results with (11)C-acetate positron emission tomography/computed tomography (PET/CT) in the staging of urinary bladder cancer Journal Article


Authors: Schoder, H.; Ong, S. C.; Reuter, V. E.; Cai, S.; Burnazi, E.; Dalbagni, G.; Larson, S. M.; Bochner, B. H.
Article Title: Initial results with (11)C-acetate positron emission tomography/computed tomography (PET/CT) in the staging of urinary bladder cancer
Abstract: Purpose: To investigate the utility of 11C-acetate positron emission tomography/computed tomography (PET/CT) for staging of bladder cancer and response assessment after neoadjuvant chemotherapy. Procedures: Seventeen patients underwent 11C-acetate PET/CT ≤1 month before radical cystectomy (RC) and pelvic lymph node dissection (PLND). Ten patients had undergone neoadjuvant chemotherapy prior to PET. Histopathology from RC and PLND (n=16) or nodal biopsy (n=1) served as gold standard. Results: Eight of 10 residual tumors showed abnormal 11C-acetate uptake; two cases of residual TiS were false negative, three cases were false positive, and three true negative. Three patients showed true positive uptake in LN. False positive uptake occurred in 14 LN regions secondary to granulomatous disease after prior intravesical Bacillus Calmette-Guerin (BCG) therapy. Conclusions: 11C-acetate has good sensitivity for bladder cancer and LN metastases. However, false positive uptake due to inflammation or granulomatous infection can occur, limiting the staging utility of 11C-acetate after prior intravesical BCG therapy. © Academy of Molecular Imaging and Society for Molecular Imaging, 2011.
Keywords: adult; clinical article; controlled study; human tissue; aged; middle aged; unclassified drug; histopathology; cancer adjuvant therapy; cancer staging; outcome assessment; lymph node metastasis; staging; cancer diagnosis; lymph nodes; neoplasm staging; disease association; bcg vaccine; controlled clinical trial; image analysis; diagnostic imaging; bladder cancer; urinary bladder neoplasms; drug accumulation; drug uptake; tissue distribution; radioactivity; computer assisted emission tomography; mycobacterium bovis; radiopharmaceutical agent; drug sensitivity; false positive result; image display; pet/ct; granulomatosis; limit of detection; acetates; positron-emission tomography and computed tomography; carbon radioisotopes; carbon acetate c 11; mycobacterium bovis bcg
Journal Title: Molecular Imaging and Biology
Volume: 14
Issue: 2
ISSN: 1536-1632
Publisher: Springer  
Date Published: 2012-04-01
Start Page: 245
End Page: 251
Language: English
DOI: 10.1007/s11307-011-0488-0
PROVIDER: scopus
PUBMED: 21491174
DOI/URL:
Notes: --- - "Export Date: 2 July 2012" - "CODEN: CPIMF" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Seng Chuan Ong
    3 Ong
  2. Guido Dalbagni
    325 Dalbagni
  3. Heiko Schoder
    550 Schoder
  4. Shangde Cai
    42 Cai
  5. Bernard Bochner
    469 Bochner
  6. Eva M Burnazi
    25 Burnazi
  7. Steven M Larson
    959 Larson
  8. Victor Reuter
    1228 Reuter
  9. Sheng Feng Cai
    50 Cai